Since Ropack’s founding in 1976 as a two-person organization in 4,000 square feet of rented space to today’s global footprint, our goal has remained the same: to consistently deliver quality and reliability to our clients. Today we operate four state-of-the-art facilities in Montreal, Canada and offer pharmaceutical contract manufacturing and packaging services for all phases of the drug development process. If you are looking for a strategic partner who stands ready to help you overcome the biggest challenges when bringing your drug to market, give us a call.
Because we have been true to our goal, Ropack Pharma Solutions counts among its client base many of the most-respected organizations in the pharmaceutical and nutraceutical industries
Ropack Pharma Solutions
10801 Mirabeau St.
Montreal, QC H1J 1T7
Contact: Paul DuPont, VP, Marketing and Business Development
There is growing interest among consumers in verifying that the dietary supplements they take are safe and efficacious. The concern over whether consumers are getting the product as it is described on the label is rooted in one vital and transformative fact: probiotics are living organisms that are highly sensitive to humidity and oxygen. In the absence of proper handling and packaging, the efficacy of probiotic products can be compromised at any point of the packaging, storage and transportation process, inversely impacting shelf life and product viability and efficacy for the consumer.
Determine your plan now for serialization readiness to put the worries of DSCSA costs and timelines behind you and patient safety back where it belongs — at the forefront.
The FDA’s intent to not enforce the requirements of the Drug Supply Chain Security Act until November 2018 offered an additional year meet compliance. The deadline for that grace period is now!
This regulation from the FDA outlined serialization and traceability requirements spread over the course of 10 years with preparation for each phase accumulating into a potentially high overall price tag.
When asked about the biggest challenges to the pharmaceutical company sponsor-contract service provider relationship, sponsors and service providers offer pretty consistent responses.
Determining a drug candidate’s probability of commercial success is a most significant phase in the drug development process. There is no room for error.
Using QRM gives a company the ability to maintain compliance while also identifying product issues that could be harmful to the consumers, some being susceptible patients.
Quality metrics have been widely used in the pharma industry to monitor quality systems, operational processes, and to promote continuous improvement initiatives in drug manufacturing.
An effective quality agreement icommunicates the responsibilities of each party in a clear, concise manner, allowing the reader to quickly and accurately determine to whom a specific responsibility is assigned.
A pharmaceutical contract services organization encounters many compounds at different phases of development and varying customer requirements. From fully developed large scale manufacturing and packaging to a single development batch, the contract services organization must be prepared to handle multiple compounds in the same facility.
The expanding global pharmaceutical industry projects a 4%-6% annual growth and forecasts that it will reach a value of $1T by 2014. By Paul Dupont
A contract packaging partner should function as an extension of the pharma’s organization, so careful consideration should be devoted to initiating this relationship.
Blister packaging, not long ago considered a less significant segment of the North American pharmaceutical packaging industry, is now outpacing most other industry segments. In 2010, blister represented 17% of the global market and recorded $8.1B in revenue, according to Pharmaceutical Packaging Industry – 2011 Yearbook. GBI Research. By Paul Dupont, Director of Business Development North America, Ropack, Inc.
Understanding the FDA audit process, preparing for it and being aware of regulations will help to restore a sense of control and help to ensure the best outcome.
Emerging countries offer a nearly untapped opportunity. Despite the opportunities, these markets also hold unique challenges. Blister packaging effectively addresses these challenges.
Trends in packaging of prescription and over-the-counter drugs indicate continued growth in the blister packaging market.
A contact packaging leader outfits its new facility with a new stick packaging line, giving pharmaceutical and nutraceutical companies another way to ease product use. By Ropack, Inc.
Ropack provides contract bottle filling of HDPE, PET, glass and flip-top vial bottles for tablets, capsules, soft/liquid gels and powders. With a bottling capacity of 20 million and 12 million for flip-top vials, Ropack brings the efficiency of five bottling lines with quick changeovers, on-line validated fill accuracy and the flexibility to accommodate small lots to commercial runs.
Ropack provides encapsulation services of solid oral dosage to the pharmaceutical, natural health product and food supplement industries in cGMP, FDA and Health Canada regulated production suites.
Ropack, Your Trusted Packaging Partner provides a number of pouch and sachet filling services for powder, solid, liquid, and other dosage types. Pouch and Sachet filling under nitrogen and pouch filling in a controlled-humidity environment are also available.
Ropack provides a number of blister packaging services and can produce blister packaging in several different forms, including regular thermo-form, cold-formed, and heat-sealed blister cards.
Ropack offers turnkey primary and secondary pharmaceutical packaging services of solid oral dosages, tablets, powder, and encapsulation into blisters, pouches, bottles, carded blisters and syringe assembly. Our facilities are cGMP compliant and FDA certified. Ropack is competitive, flexible and agile; supporting clinical trials, short run start-ups, commercial production and warehousing and distribution services for over 100 U.S., Canadian and European pharmaceutical and nutraceutical customers.
Ropack, Your Trusted Packaging Partner provides Stick-Pack Packaging. Stick-packs offer consumers the convenience and flexibility their active lives demand. An ideal format for pediatric and geriatric formulations. Stick-packs offer consumers the convenience and flexibility their active lives demand. An ideal format for pediatric and geriatric formulations.
Ropack, Your trusted packaging partner produces exact filling of HDPE, PET and Glass bottles. Bottles are sealed with induction seals, permaseals, and child-resistant or senior-friendly caps.
Ropack, Your Trusted Packaging Partner provides in-Canada clinical trial distribution reduces costs and shortens go-to-market timelines while ensuring accuracy and the highest level of security.
Ropack's in-Canada clinical trial distribution reduces costs and shortens go-to-market timelines while ensuring accuracy and the highest level of security. When pharmas and CROs send bulk product, Ropack purchases components in country and eliminates the governmental red tape and associated cost of shipping from out of country.
Contract packaging for pharmaceutical and consumer health-care is Ropack's core service. Global customers rely on our exacting production environments — 32 Class 100000 Clean Rooms, including a dedicated facility ensuring low RH and controlled temperature. With four production facilities totaling nearly 250,000 square feet, Ropack has ample capacity, state-of-the-industry technology and the flexibility to provide stability and commercial production in short and long runs.